\
&
Contact us
\
&
Contact us
This was 2 years ago
LocationOnline
ProgrammesThe Innovative Health Initiative (IHI) has recently published draft information on future calls ahead of official publication to give applicants additional time to prepare a strong proposal. Find more information here.
The upcoming IHI Call Days will provide potential applicants with the information they need to put together a strong proposal, and give them the opportunity to identify and meet partners for their consortia.
In the series covering Call 3, the following webinars are scheduled:
You can hold matchmaking meetings via the platform at any time until the deadline for submitting proposals.
More information and registration on the IHI website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
